PCI-27483

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NamePCI-27483
Drug Alias NamePCI-27483CRA-027483
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor VIIa inhibitors
TargetsCoagulation factor VII
Therapy Area/IndicationsPancreatic NeoplasmsAdenocarcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPharmacyclics Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmacyclics Llc
Active IndicationsN/A
Inactive IndicationsPancreatic NeoplasmsAdenocarcinoma

Other Information

ATC CodeN/A
Related LinksN/A